Carlumab, an anti-C-C chemokine ligand 2 monoclonal antibody, in combination with four chemotherapy regimens for the treatment of patients with solid tumors: an open-label, multicenter phase 1b study.
about
Targeting the CCL2-CCR2 signaling axis in cancer metastasisThe interaction of anticancer therapies with tumor-associated macrophagesTargeting tumor-associated macrophages to combat pancreatic cancerPhase Ib study of duligotuzumab (MEHD7945A) plus cisplatin/5-fluorouracil or carboplatin/paclitaxel for first-line treatment of recurrent/metastatic squamous cell carcinoma of the head and neck.The Yin/Yan of CCL2: a minor role in neutrophil anti-tumor activity in vitro but a major role on the outgrowth of metastatic breast cancer lesions in the lung in vivo.Functional TRAIL receptors in monocytes and tumor-associated macrophages: A possible targeting pathway in the tumor microenvironmentTumor-associated macrophages: from basic research to clinical application.Tanshinone IIA Inhibits Epithelial-Mesenchymal Transition in Bladder Cancer Cells via Modulation of STAT3-CCL2 Signaling.Tumor-associated macrophages and anti-tumor therapies: complex links.The Promise of Targeting Macrophages in Cancer Therapy.Tumour-associated macrophages as treatment targets in oncology.Tumor-associated macrophages: implications in cancer immunotherapy.Tumor-Associated Macrophages as Target for Antitumor Therapy.Continuous Delivery of Neutralizing Antibodies Elevate CCL2 Levels in Mice Bearing MCF10CA1d Breast Tumor Xenografts.Reprogramming of Tumor-Associated Macrophages with Anticancer Therapies: Radiotherapy versus Chemo- and ImmunotherapiesTumor-associated macrophages, potential targets for cancer treatment.Investigation of proliferation and migration of tongue squamous cell carcinoma promoted by three chemokines, MIP-3α, MIP-1β, and IP-10.Plasma MCP-1 and Cognitive Decline in Patients with Alzheimer's Disease and Mild Cognitive Impairment: A Two-year Follow-up Study.Tumor Associated Macrophages as Therapeutic Targets for Breast Cancer.Targeting Macrophages in Cancer: From Bench to Bedside.Multifaceted Roles for Macrophages in Prostate Cancer Skeletal Metastasis.Estrogen promotes progression of hormone-dependent breast cancer through CCL2-CCR2 axis by upregulation of Twist via PI3K/AKT/NF-κB signaling.Regulation of Ovarian Cancer Prognosis by Immune Cells in the Tumor Microenvironment
P2860
Q26765184-47838D58-DCBF-482D-A047-693D23F84FD8Q27016634-F0F3D2C1-652D-42D2-8B30-B5EC1F744CECQ28076103-A51896B4-B81A-41C4-B145-53F56F00AF47Q33434648-75F2D5EB-A654-49F3-AF3E-1E1BE47D1DE8Q36265616-BC29C0FE-F6EC-4CC4-80E9-602FA7C5B466Q37520325-5C757081-981A-4105-9B13-AC1AAC84FEA3Q37671174-3DA1CFAE-343C-4A75-8668-EBAAF7CDF86BQ38652688-A95102CC-D675-4EC7-9B49-B09C45E54C98Q38766176-99BA36DE-5819-4A03-B2A0-747541398C75Q38877313-BD594350-6D2A-4AC2-A0CD-0179B6682462Q39100693-781206EE-F9FB-45CC-A6EB-77A17EE224CFQ39148281-10683697-5267-4225-B294-D3040B9EAB8DQ39403895-6BEBF79B-520A-46CB-9A55-193F6022AEB9Q40124047-75C07A1C-62E2-4CE2-A9C0-E1E128F993D0Q41011622-265A81E2-9AE1-4856-8627-0772C08DDF18Q41318642-380DFC98-10B1-4194-A012-849A49DE517EQ41633780-486AC3E9-3A05-4816-9F9F-5046CFABB47AQ47553904-DFCD95CC-088D-4E44-80B0-054C575151CDQ49544289-7977DBC9-8F71-4908-9411-876491A87141Q55315292-23E49064-5FF8-43EB-BF37-8C21BBE722C0Q55364968-1FAD8C35-BA9B-402E-BB7D-5D14AAED7F4FQ55498606-E048C738-F460-4DE2-A491-3BB900858B72Q58773649-E081D15C-44A5-4E0D-91A9-C6F10DFFAD8F
P2860
Carlumab, an anti-C-C chemokine ligand 2 monoclonal antibody, in combination with four chemotherapy regimens for the treatment of patients with solid tumors: an open-label, multicenter phase 1b study.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Carlumab, an anti-C-C chemokin ...... l, multicenter phase 1b study.
@ast
Carlumab, an anti-C-C chemokin ...... l, multicenter phase 1b study.
@en
type
label
Carlumab, an anti-C-C chemokin ...... l, multicenter phase 1b study.
@ast
Carlumab, an anti-C-C chemokin ...... l, multicenter phase 1b study.
@en
prefLabel
Carlumab, an anti-C-C chemokin ...... l, multicenter phase 1b study.
@ast
Carlumab, an anti-C-C chemokin ...... l, multicenter phase 1b study.
@en
P2093
P2860
P1433
P1476
Carlumab, an anti-C-C chemokin ...... l, multicenter phase 1b study.
@en
P2093
Carla J de Boer
Emiliano Calvo
Irene Brana
Lorrin K Yee
Patricia M LoRusso
Shobha Seetharam
Thomas A Puchalski
P2860
P2888
P304
P356
10.1007/S11523-014-0320-2
P577
2014-06-15T00:00:00Z
P5875
P6179
1020117776